Literature DB >> 15176691

Exercise testing in pulmonary arterial hypertension and in chronic heart failure.

G Deboeck1, G Niset, M Lamotte, J L Vachiéry, R Naeije.   

Abstract

Exercise capacity is reduced in pulmonary arterial hypertension and in chronic left heart failure, but it is not known whether the cardiopulmonary exercise testing profile is different in the two conditions at the same severity of functional limitation. Nineteen patients with pulmonary arterial hypertension and 19 with chronic heart failure underwent a 6-min walk test and symptom-limited maximal incremental cycle ergometry. The patients with pulmonary arterial hypertension and chronic heart failure did not differ in New York Heart Association Functional Class (mean +/- SEM 2.8 +/- 0.1 versus 2.8 +/- 0.2), 6-min walking distance (395 +/- 30 versus 419 +/- 20 m), peak work-rate, oxygen consumption, ventilation and cardiac frequency. However, patients with pulmonary arterial hypertension exhibited higher dyspnoea scores (5.8 +/- 0.6 versus 3.8 +/- 0.5) higher ventilatory equivalents for carbon dioxide (58 +/- 3 versus 44 +/- 3 at the anaerobic threshold) and lower peak oxygen pulse (5.9 +/- 0.4 versus 8.7 +/- 0.5 mL x beat(-1), or 53 +/- 4 versus 64 +/- 4% of the predicted value). It is concluded that the cardiopulmonary exercise testing profile in pulmonary arterial hypertension differs from that in chronic heart failure by showing more dyspnoea at comparable work-rates, related to greater reductions in ventilatory efficiency and stroke volume.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176691     DOI: 10.1183/09031936.04.00111904

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

Review 1.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.

Authors:  Adriano R Tonelli; Laith Alkukhun; Vineesha Arelli; José Ramos; Jennie Newman; Kevin McCarthy; Bohdan Pichurko; Omar A Minai; Raed A Dweik
Journal:  Clin Transl Sci       Date:  2013-09-06       Impact factor: 4.689

Review 3.  Assessment of hypoxia in children with cystic fibrosis.

Authors:  D S Urquhart; H Montgomery; A Jaffé
Journal:  Arch Dis Child       Date:  2005-11       Impact factor: 3.791

4.  Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.

Authors:  Akifumi Higashi; Yoshihiro Dohi; Sayuri Yamabe; Hiroki Kinoshita; Yoshiharu Sada; Toshiro Kitagawa; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Yuji Yasunobu; Yasuki Kihara
Journal:  Heart Vessels       Date:  2017-05-30       Impact factor: 2.037

5.  Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Emmy Manders; Peter I Bonta; Jaap J Kloek; Petr Symersky; Harm-Jan Bogaard; Pleuni E Hooijman; Jeff R Jasper; Fady I Malik; Ger J M Stienen; Anton Vonk-Noordegraaf; Frances S de Man; Coen A C Ottenheijm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

6.  Exercise-induced pulmonary arterial hypertension.

Authors:  James J Tolle; Aaron B Waxman; Teresa L Van Horn; Paul P Pappagianopoulos; David M Systrom
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

7.  lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia.

Authors:  Yiying Li; Junting Zhang; Hanliang Sun; Yujie Chen; Wendi Li; Xiufeng Yu; Xijuan Zhao; Lixin Zhang; Jianfeng Yang; Wei Xin; Yuan Jiang; Guilin Wang; Wenbin Shi; Daling Zhu
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

8.  Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing.

Authors:  Daniel Dumitrescu; Ronald J Oudiz; George Karpouzas; Arsen Hovanesyan; Amali Jayasinghe; James E Hansen; Stephan Rosenkranz; Karlman Wasserman
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

9.  Exercise intolerance in pulmonary arterial hypertension.

Authors:  Robin M Fowler; Kevin R Gain; Eli Gabbay
Journal:  Pulm Med       Date:  2012-06-10

10.  Clinical usefulness of response profiles to rapidly incremental cardiopulmonary exercise testing.

Authors:  Roberta P Ramos; Maria Clara N Alencar; Erika Treptow; Flávio Arbex; Eloara M V Ferreira; J Alberto Neder
Journal:  Pulm Med       Date:  2013-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.